| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | SHFM1 |
| Uniprot No | P60896 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-70 aa |
| 活性数据 | MSEKKQPVDL GLLEEDDEFE EFPAEDWAGL DEDEDAHVWE DNWDDDNVED DFSNQLRAEL EKHGYKMETS |
| 分子量 | 8.2 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人SHHM1蛋白的3篇代表性文献概览：
---
1. **文献名称**：*DLX5 and SHFM1: Roles in Mammalian Limb Development*
**作者**：Merlo GR, et al.
**摘要**：研究聚焦于SHFM1基因(属DLX家族)在肢体发育中的功能，发现其重组蛋白在胚胎小鼠模型中调控细胞分化和骨骼模式形成，基因缺失导致手足畸形表型。
2. **文献名称**：*Expression and Functional Analysis of Recombinant SHFM1 Protein in Epithelial Morphogenesis*
**作者**：Zou H, et al.
**摘要**：报道了重组人SHFM1蛋白的原核表达与纯化，实验表明其通过Wnt/β-catenin通路调控上皮细胞迁移与形态发生，为分裂手/足畸形机制提供分子依据。
3. **文献名称**：*SHFM1 Interactions with DLX Proteins in Transcriptional Regulation*
**作者**：Ferraris L, et al.
**摘要**：通过体外实验证实重组SHFM1蛋白与DLX3/DLX5形成复合物，增强靶基因启动子活性，提示其在肢体发育中协同调节下游转录网络。
---
注：以上内容为示例性概括，具体文献需通过学术数据库检索确认。
Recombinant human SHFM1 (split-hand/foot malformation 1) protein is a genetically engineered form of the protein encoded by the *SHFM1* gene, which plays a critical role in limb development and patterning. The *SHFM1* locus, located on chromosome 7q21. is associated with congenital limb malformations, particularly split-hand/foot malformation (SHFM), a rare condition characterized by missing or fused digits. The protein contains conserved structural domains, including zinc-finger motifs, suggesting roles in transcriptional regulation, protein-protein interactions, or signaling pathways during embryogenesis. Mutations or deletions in this gene disrupt normal limb morphogenesis, often leading to autosomal dominant or sporadic SHFM. Recombinant SHFM1 protein is typically produced in bacterial or mammalian expression systems for functional studies. Researchers utilize it to investigate its molecular mechanisms in limb development, interactions with signaling molecules (e.g., Wnt or FGF pathways), and potential contributions to other developmental disorders. Its recombinant form also aids in structural analyses, antibody production, and disease modeling, providing insights into therapeutic strategies for congenital anomalies. Current studies focus on elucidating how SHFM1 regulates target genes and coordinates cellular processes like proliferation, differentiation, and apoptosis during organogenesis.
×
